Pfizer COVID-19 Vaccine Could Cut Transmission by Half: Company Executive
MONDAY, Nov. 16, 2020 -- The BioNTech and Pfizer experimental COVID-19 vaccine could cut transmission of the virus in half, leading to a "dramatic" curb of its spread, according to a company executive.
"I'm very confident that transmission between people will be reduced by such a highly effective vaccine -- maybe not 90 percent but maybe 50 percent," said Ugur Sahin, chief executive of Germany's BioNTech, the Associated Press reported.
Last week, the companies claimed the vaccine was 90 percent effective in protecting people from the new coronavirus.
"If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year," Sahin said. "Our goal is to deliver more than 300 million vaccine doses until April next year, which could allow us to already start to make an impact."
Researchers are gathering more information on safety and manufacturing quality of the vaccine, the AP reported.
© 2021 HealthDay. All rights reserved.
Posted: November 2020
Further Support and Information on COVID-19
Read this next
WEDNESDAY, Jan. 27, 2021 -- Certain risk factors are associated with college students self-reporting a psychological impact of the COVID-19 pandemic, according to a study...
WEDNESDAY, Jan. 27, 2021 -- Retired doctors and nurses are being called to the front lines of the U.S. COVID-19 vaccination effort, the White House COVID-19 Response team...
WEDNESDAY, Jan. 27, 2021 -- For patients hospitalized with COVID-19, respiratory, physical, and psychological sequelae are common at four months after discharge, according to a...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.